These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22143126)

  • 21. Achievement of therapeutic international normalized ratio following adjustment of tube feeds.
    Krajewski KC; Butterfoss K
    J Clin Pharmacol; 2011 Mar; 51(3):440-3. PubMed ID: 20538908
    [No Abstract]   [Full Text] [Related]  

  • 22. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M
    JPEN J Parenter Enteral Nutr; 2004; 28(6):388-98. PubMed ID: 15568285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin--indications, risks and drug interactions.
    Tadros R; Shakib S
    Aust Fam Physician; 2010 Jul; 39(7):476-9. PubMed ID: 20628660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
    Gunther KE; Conway G; Leibach L; Crowther MA
    Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
    Crowther MA; Garcia D; Ageno W; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Schulman S; Kovacs M; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
    Thromb Haemost; 2010 Jul; 104(1):118-21. PubMed ID: 20458438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why warfarin and heparin need to overlap when treating acute venous thromboembolism.
    Wittkowsky AK
    Dis Mon; 2005; 51(2-3):112-5. PubMed ID: 15900262
    [No Abstract]   [Full Text] [Related]  

  • 28. Dietary vitamin K guidance: an effective strategy for stable control of oral anticoagulation?
    Booth SL
    Nutr Rev; 2010 Mar; 68(3):178-81. PubMed ID: 20384848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature.
    MacLaren R; Wachsman BA; Swift DK; Kuhl DA
    Pharmacotherapy; 1997; 17(6):1331-7. PubMed ID: 9399621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
    Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
    Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.
    Schulman S; Lindmarker P; Holmström M; Lärfars G; Carlsson A; Nicol P; Svensson E; Ljungberg B; Viering S; Nordlander S; Leijd B; Jahed K; Hjorth M; Linder O; Beckman M
    J Thromb Haemost; 2006 Apr; 4(4):734-42. PubMed ID: 16634738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy.
    Leblanc C; Presse N; Lalonde G; Dumas S; Ferland G
    Thromb Res; 2014 Jul; 134(1):210-2. PubMed ID: 24824293
    [No Abstract]   [Full Text] [Related]  

  • 37. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 38. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral administration of intravenous preparation of Vitamin K for excessive anticoagulation due to warfarin].
    Lozada Y; Falcone M; Granero R
    Medicina (B Aires); 2012; 72(2):115-8. PubMed ID: 22522851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral anticoagulant therapy. Fundamentals, clinical practice and recommendations.
    Lemos Silva R; Carvalho de Sousa J; Calisto C; Braz Nogueira JM; Ravara L
    Rev Port Cardiol; 2007; 26(7-8):769-88. PubMed ID: 17939586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.